Sign up USA
Proactive Investors - Run By Investors For Investors
Market: NASDAQ
Sector: Pharma & Biotech
Acceleron Pharma Inc

Acceleron Pharma Inc

Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body’s remarkable capacity for cellular growth and repair. Our approach to drug discovery is driven by deep scientific expertise—and an urgency to deliver effective treatments to thousands of patients who have few or no therapeutic options. The Company’s lead product candidate, luspatercept, is being evaluated in two Phase 3 studies in a global partnership with Celgene to treat chronic, sometimes debilitating anemias in myelodysplastic syndromes (MDS) and beta-thalassemia. We are also advancing clinical programs in neuromuscular disorders and preclinical research in fibrotic and other diseases.

Acceleron Pharma Inc

Interactive graph

col 3
col 4
col 5
col 6

Acceleron Pharma Inc Timeline

Copyright ©, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use